디지털 헬스케어 시대의 불면증 치료: 현재와 미래
Insomnia Treatment in the Digital Healthcare Era: Present and Future
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Insomnia is a prevalent sleep disorder characterized by difficulties in falling asleep, frequent awakenings, or waking up too early. These disturbances adversely affect patient’s health. Although numerous insomnia treatment guidelines recommend cognitive behavioral therapy for insomnia (CBT-I) as the primary treatment approach, its clinical effectiveness has been hampered because of challenges such as insurance concerns, limited healthcare accessibility, inadequate compensation for providers, and a shortage of specialists. To address these limitations, CBT-I should be implemented as a digital therapeutic modality. Internationally, products such as Somryst, Sleepio, CBT-I Coach, Night Owl-Sleep Coach, and Minddistrict have been utilized. In South Korea, emerging digital therapeutic devices such as Somzz and PilLow Rx are also being introduced. In this review, we explored the current status of digital therapeutic modalities for insomnia in both international and domestic markets, aiming to provide insights into the future prospects in the realm of insomnia treatment in the modern digital healthcare era.
Abstract
Insomnia is a prevalent sleep disorder characterized by difficulties in falling asleep, frequent awakenings, or waking up too early. These disturbances adversely affect patient’s health. Although numerous insomnia treatment guidelines recommend cognitive behavioral therapy for insomnia (CBT-I) as the primary treatment approach, its clinical effectiveness has been hampered because of challenges such as insurance concerns, limited healthcare accessibility, inadequate compensation for providers, and a shortage of specialists. To address these limitations, CBT-I should be implemented as a digital therapeutic modality. Internationally, products such as Somryst, Sleepio, CBT-I Coach, Night Owl-Sleep Coach, and Minddistrict have been utilized. In South Korea, emerging digital therapeutic devices such as Somzz and PilLow Rx are also being introduced. In this review, we explored the current status of digital therapeutic modalities for insomnia in both international and domestic markets, aiming to provide insights into the future prospects in the realm of insomnia treatment in the modern digital healthcare era.
참고문헌 (49)
- Schutte-Rodin S, "Clinical guideline for the evaluation and management of chronic insomnia in adults", J Clin Sleep Med, 4, pp.487~504 (2008)[DOI]
- Rosenberg R, "Advances in the treatment of chronic insomnia : a narrative review of new nonpharmacologic and pharmacologic therapies", Neuropsychiatr Dis Treat, 17, pp.2549~2566 (2021)[DOI]
- Morin CM, "Endorsement of European guideline for the diagnosis and treatment of insomnia by the World Sleep Society", Sleep Med, 81, pp.124~126 (2021)[DOI]
- Chung S, "Korean clinical practice guideline for management of insomnia in adults", Korean Neuropsychiatric Association, ~ (2019)
- Perils ML, "How can we make CBT-I and other BSM services widely available?", J Clin Sleep Med, 4, pp.11~13 (2008)[DOI]
- Edinger JD, "Behavioral and psychological treatments for chronic insomnia disorder in adults : an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment", J Clin Sleep Med, 17, pp.263~298 (2021)[DOI]
- Edinger JD, "Behavioral and psychological treatments for chronic insomnia disorder in adults : an American Academy of Sleep Medicine clinical practice guideline", J Clin Sleep Med, 17, pp.255~262 (2021)[DOI]
- 정석훈, "암 환자의 불면증과 수면장애, 어떻게 관리할 것인가?", Journal of sleep medicine, 17(1), pp.11~18 (2020), 대한수면연구학회[DOI]
- 이은, "불면증의 인지행동치료", 대한의사협회지, 63(8), pp.477~483 (2020), 대한의사협회
- 이장원, "수면장애에 대한 인지행동 치료 효과에 대한 체계적 문헌 고찰 개관", 대한한의학회지, 43(2), pp.75~91 (2022), 대한한의학회
- Ministry of Food and Drug Safety, "Digital Therapy Device Authorization Review Guidelines. 1st ed", Ministry of Food and Drug Safety, National Institute of Food and Drug Safety Evaluation, ~ (2020)
- Choi Y, "Digital Health Care : The Future of Healthcare" (2020), CLOUD 9
- 조철현, "불면증 디지털 치료제의 임상 적용", 수면정신생리, 28(1), pp.6~12 (2021), 대한수면의학회[DOI]
- Erten Uyumaz B, "A review of digital cognitive behavioral therapy for insomnia(CBT-I apps) : are they designed for engagement?", Int J Environ Res Public Health, 18, pp.2929~ (2021)[DOI]
- Luik AI, "Digital delivery of cognitive behavioral therapy for insomnia", Curr Psychiatry Rep, 21, pp.50~ (2019)[DOI]
- Simon L, "Comparative efficacy of onsite, digital, and other settings for cognitive behavioral therapy for insomnia : a systematic review and network meta-analysis", Sci Rep, 13, pp.1929~ (2023)[DOI]
- Ritterband LM, "Efficacy of an internet-based behavioral intervention for adults with insomnia", Arch Gen Psychiatry, 66, pp.692~698 (2009)[DOI]
- Morin CM, "Profile of Somryst prescription digital therapeutic for chronic insomnia : overview of safety and efficacy", Expert Rev Med Devices, 17, pp.1239~1248 (2020)[DOI]
- Christensen H, "Effectiveness of an online insomnia program(SHUTi)for prevention of depressive episodes(the GoodNight study) : a randomised controlled trial", Lancet Psychiatry, 3, pp.333~341 (2016)[DOI]
- Ritterband LM, "Effect of a web-based cognitive behavior therapy for insomnia intervention with 1-year follow-up : a randomized clinical trial", JAMA Psychiatry, 74, pp.68~75 (2017)[DOI]
- Ritterband LM, "Real-world evidence from users of a behavioral digital therapeutic for chronic insomnia", Behav Res Ther, 153, pp.104084~ (2022)[DOI]
- Forma F, "Real-world evaluation of clinical response and long-term healthcare resource utilization patterns following treatment with a digital therapeutic for chronic insomnia", Clinicoecon Outcomes Res, 14, pp.537~546 (2022)[DOI]
- "Pear therapeutics files for bankruptcy as CEO blames shortfalls on insurers" (2023)[URL]
- "Nox Health acquires Somryst, the only FDA-cleared digital insomnia treatment, further elevating its behavioral sleep care management program" (2023)[URL]
- Espie CA, "A randomized, placebo-controlled trial of online cognitive behavioral therapy for chronic insomnia disorder delivered via an automated media-rich web application", Sleep, 35, pp.769~781 (2012)[DOI]
- Espie CA, "Insomniacs’ attributions : psychometric properties of the dysfunctional beliefs and attitudes about sleep scale and the sleep disturbance questionnaire", J Psychosom Res, 48, pp.141~148 (2000)[DOI]
- Wicklow A, "Intrusive thoughts and their relationship to actigraphic measurement of sleep : towards a cognitive model of insomnia", Behav Res Ther, 38, pp.679~693 (2000)[DOI]
- Harvey KJ, "Development and preliminary validation of the Glasgow content of thoughts inventory(GCTI) : a new measure for the assessment of pre-sleep cognitive activity", Br J Clin Psychol, 43(Pt 4), pp.409~420 (2004)[DOI]
- Henry JD, "The short-form version of the depression anxiety stress scales(DASS-21) : construct validity and normative data in a large non-clinical sample", Br J Clin Psychol, 44(Pt 2), pp.227~239 (2005)[DOI]
- Espie CA, "The sleep condition indicator : a clinical screening tool to evaluate insomnia disorder", BMJ Open, 4, pp.e004183~ (2014)[DOI]
- Espie CA, "Attribution, cognition and psychopathology in persistent insomnia disorder : outcome and mediation analysis from a randomized placebo-controlled trial of online cognitive behavioural therapy", Sleep Med, 15, pp.913~917 (2014)[DOI]
- Espie CA, "Effect of digital cognitive behavioral therapy for insomnia on health, psychological well-being, and sleeprelated quality of life : a randomized clinical trial", JAMA Psychiatry, 76, pp.21~30 (2019)[DOI]
- Sweetman A, "Implementation of a digital cognitive behavioral therapy for insomnia pathway in primary care", Contemp Clin Trials, 107, pp.106484~ (2021)[DOI]
- Stott R, "Does adjunctive digital CBT for insomnia improve clinical outcomes in an improving access to psychological therapies service?", Behav Res Ther, 144, pp.103922~ (2021)[DOI]
- Kuhn E, "CBT-I coach : a description and clinician perceptions of a mobile app for cognitive behavioral therapy for insomnia", J Clin Sleep Med, 12, pp.597~606 (2016)[DOI]
- Koffel E, "A randomized controlled pilot study of CBT-I coach : feasibility, acceptability, and potential impact of a mobile phone application for patients in cognitive behavioral therapy for insomnia", Health Informatics J, 24, pp.3~13 (2018)[DOI]
- Reilly ED, "Mobile intervention to improve sleep and functional health of veterans with insomnia : randomized controlled trial", JMIR Form Res, 5, pp.e29573~ (2021)[DOI]
- Kuhn E, "A pilot randomized controlled trial of the insomnia coach mobile app to assess its feasibility, acceptability, and potential efficacy", Behav Ther, 53, pp.440~457 (2022)[DOI]
- Miller KE, "Clinician perceptions related to the use of the CBT-I coach mobile app", Behav Sleep Med, 17, pp.481~491 (2019)[DOI]
- Harbison BR, "0408. Evaluation of a CBT-I self-help program administered by a mobile app", Sleep, 41, pp.A155~ (2018)[DOI]
- van Straten A, "Guided Internet-delivered cognitive behavioural treatment for insomnia : a randomized trial", Psychol Med, 44, pp.1521~1532 (2014)[DOI]
- Lancee J, "Motivational support provided via email improves the effectiveness of internet-delivered self-help treatment for insomnia : a randomized trial", Behav Res Ther, 51, pp.797~805 (2013)[DOI]
- Horsch CH, "Mobile phone-delivered cognitive behavioral therapy for insomnia : a randomized waitlist controlled trial", J Med Internet Res, 19, pp.e70~ (2017)[DOI]
- Ministry of Food and Drug Safety, "Guidelines for Safety and Performance Evaluation and Clinical Trial Protocol Writing for Digital Therapeutic Devices for Insomnia", Ministry of Food and Drug Safety, National Institute of Food and Drug Safety Evaluation, ~ (2021)
- "Somzz"[URL]
- Gam HJ, "Method of treatement for insomnia" (2022), Korean Intellectual Property Office
- Gam HJ, "Appartus for providing treatment service for insomnia based on learning algorithm" (2023), Korean Intellectual Property Office
- Park KM, "Prediction of good sleep with physical activity and light exposure : a preliminary study", J Clin Sleep Med, 18, pp.1375~1383 (2022)[DOI]
- Choi HJ, "Digital therapeutics reimbursement system in Germany and its implications", HIRA Res, 2, pp.24~35 (2022)[DOI]
